Literature DB >> 26747623

Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.

Ian S Mutchnick1, Meena A Thatikunta2, William C Gump3, Dan L Stewart4, Thomas M Moriarty3.   

Abstract

PURPOSE: Ventriculomegaly in infants with congenital myotonic dystrophy (CDM) is common, and the neurosurgical determination of shunting is complex. The natural history of CDM-associated ventriculomegaly from prenatal to natal to postnatal stages is poorly known. The relationship between macrocephaly and ventriculomegaly, incidence of shunt necessity, and early mortality outcomes lack pooled data analysis. This study aims to review clinical features and pathophysiology of CDM, with emphasis on ventriculomegaly progression, ventriculomegaly association with macrocephaly, and incidence of shunting.
METHODS: This is a literature review with pooled data analysis and case report.
RESULTS: One hundred four CDM patients were reviewed in 13 articles that mentioned CDM with ventriculomegaly and/or head circumference. Data was very limited: only 7 patients had data on the presence or absence of prenatal ventriculomegaly, 97 on ventriculomegaly at birth, and 32 on whether or not the ventricles enlarged post-natally. Three patients of 7 (43 %) had pre-natally diagnosed ventriculomegaly, 43 of 97 (44 %) had ventriculomegaly at birth, and only 5 of 32 (16 %) had progressive enlargement of ventricles post-natally. Only 5 of 104 patients had a documented shunt placement: 1 for obstructive, 1 for a post-hemorrhagic communicating, 2 for a communicating hydrocephalus without hemorrhage, and 1 with unknown indication. Of 13 macrocephalic patients with data about ventricular size, 12 had ventriculomegaly.
CONCLUSIONS: Ventriculomegaly occurs regularly with CDM but most often does not require CSF diversion. Decisions regarding neurosurgical intervention will necessarily be based on limited information, but shunting should only occur once dynamic data confirms hydrocephalus.

Entities:  

Keywords:  Genetic; Hydrocephalus; Macrocephaly; Neonatal

Mesh:

Year:  2016        PMID: 26747623     DOI: 10.1007/s00381-015-2993-y

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  46 in total

1.  Occlusive hydrocephalus in congenital myotonic dystrophy.

Authors:  W Rettwitz-Volk; M Wikstroem; O Flodmark
Journal:  Brain Dev       Date:  2001-03       Impact factor: 1.961

2.  Congenital myotonic dystrophy in Britain. I. Clinical aspects.

Authors:  P S Harper
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

3.  Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat.

Authors:  A Mankodi; E Logigian; L Callahan; C McClain; R White; D Henderson; M Krym; C A Thornton
Journal:  Science       Date:  2000-09-08       Impact factor: 47.728

4.  Brain MRI features of congenital- and adult-form myotonic dystrophy type 1: case-control study.

Authors:  Alfonso Di Costanzo; Francesco Di Salle; Lucio Santoro; Vincenzo Bonavita; Gioacchino Tedeschi
Journal:  Neuromuscul Disord       Date:  2002-06       Impact factor: 4.296

5.  Cerebral abnormalities in congenital myotonic dystrophy.

Authors:  A Garcia-Alix; F Cabañas; C Morales; A Pellicer; J Echevarria; L Paisan; J Quero
Journal:  Pediatr Neurol       Date:  1991 Jan-Feb       Impact factor: 3.372

6.  Myotonic dystrophy in pregnancy. Prenatal, neonatal and maternal considerations.

Authors:  M A Nazir; W P Dillon; E W McPherson
Journal:  J Reprod Med       Date:  1984-03       Impact factor: 0.142

7.  Neuroimaging study of myotonic dystrophy. I. Magnetic resonance imaging of the brain.

Authors:  T Hashimoto; M Tayama; M Miyazaki; K Murakawa; H Kawai; H Nishitani; Y Kuroda
Journal:  Brain Dev       Date:  1995 Jan-Feb       Impact factor: 1.961

8.  Congenital myotonic dystrophy: assisted ventilation duration and outcome.

Authors:  Craig Campbell; Rebecca Sherlock; Pierre Jacob; Marc Blayney
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

9.  Maturational arrest of fetal muscle in neonatal myotonic dystrophy. A pathologic study of four cases.

Authors:  H B Sarnat; S W Silbert
Journal:  Arch Neurol       Date:  1976-07

10.  Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues.

Authors:  K L Taneja; M McCurrach; M Schalling; D Housman; R H Singer
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  2 in total

1.  Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1.

Authors:  Siham Ait Benichou; Dominic Jauvin; Thiéry De Serres-Bérard; Marion Pierre; Karen K Ling; C Frank Bennett; Frank Rigo; Genevieve Gourdon; Mohamed Chahine; Jack Puymirat
Journal:  Gene Ther       Date:  2022-01-25       Impact factor: 5.250

Review 2.  Myotonic Dystrophies: State of the Art of New Therapeutic Developments for the CNS.

Authors:  Genevieve Gourdon; Giovanni Meola
Journal:  Front Cell Neurosci       Date:  2017-04-20       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.